Document is current
Any future updates will be listed below
-
Authors
Duan, Zongshuan
Levine, Hagai
Bar-Zeev, Yael
Cui, Yuxian
LoParco, Cassidy R.
Wang, Yan
Abroms, Lorien C.
Khayat, Amal
Berg, Carla J. http://orcid.org/0000-0001-8931-1961
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA239178)
- License Information
-
More Information
Article History
Received: 6 August 2023
Accepted: 8 November 2023
First Online: 13 November 2023
Declarations
:
: This study was approved by the institutional review boards of George Washington University (NCR213416) and Hebrew University (27062021). All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all study participants.
: Not applicable.
: H.L. had received fees for lectures from Pfizer Israel Ltd. (distributor of a smoking cessation pharmacotherapy in Israel) in 2017. Y.B.-Z. has received fees for lectures from Pfizer, Novartis NCH and GSK Consume Health (distributors of pharmacotherapy in Israel) in the past (2012–July 2019). L.C.A. receives royalties for the sale of Text2Quit. No other conflicts of interest are declared.
